In recent decades rapidly increasing bacteria resistance to commonly used antibiotics has become an urgent healthcare challenge, especially affecting individuals with compromised immune system [1]. Opportunistic multidrug-resistant gram-negative bacterium Stenotrophomonas maltophilia has gained prominence due to challenging infections and resistance to commonly used antibiotics. Although S. maltophilia resistance to clinically important beta-lactam antibiotics is well-observed, only two beta-lactamases L1 and L2 are currently documented and described [2]. Initial research of beta-lactam resistant S. maltophilia SM3 strain indicated that other previously undescribed genes might code beta-lactamases.
The aim of this study is to analyse putative S. maltophilia beta-lactamases and evaluate their enzymatic activity. Putative beta-lactamases were bioinformatically analysed using Beta-Lactamase DataBase [3]. In order to test selected putative beta-lactamases function, analysed genes will be cloned into expression plasmid, functional activity will be examined in Escherichia coli expression strain using beta-lactamase activity specific nitrocefin test.
The bioinformatic analysis showed that ten analysed proteins are homologous to known beta-lactamases, proteins identity reaching 24.8% to 29.5%. The methodology for detecting enzymatic beta-lactamase activity was successfully tested on a known beta-lactamase L1 and functional activity of remaining putative beta-lactamases will be evaluated using the same approach.